Schemmer, P; Nashan, B; Braun, F; Pascher, A; Klein, CG; Neumann, U; Kroeger, I; Wimmer, P; Schlitt, HJ.
HEPHAISTOS study: Early use of everolimus plus reduced tacrolimus in de novo liver transplant recipients achieves high efficacy and safety compared to standard tacrolimus.
TRANSPLANTATION. 2019; 103(8):298-298.-25th Annual International Congress of the International-Liver-Transplantation-Society (ILTS); MAY 15-18, 2019; Toronto, CANADA.
[Oral Communication]
Web of Science